Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors

1

Review clinical trials related to Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid

This is a phase Ⅲ, multicenter, randomized, double-blind, study to evaluate the efficacy and safety of JMT103 in patients with bone metastases from malignant solid tumors. The purpose of this study is to determine if JMT103 is non-inferior to zoledronic acid.

Participants needed: 1,360
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: Jan 24, 2024
Eligibility criteria

Age: older than 18 years; [+4]

Previous or ongoing osteomyelitis or osteonecrosis of the jaw; dental or oral su... [+6]